Organization
SymBio Pharmaceuticals
9 clinical trials
Clinical trial
Phase II, Open-label, Randomized, Multiple Ascending Dose Confirmation of the Safety and Tolerability of Brincidofovir in Subjects With BK Virus Infection (Viremia) After Kidney Transplantation (BASTION)Status: Recruiting, Estimated PCD: 2024-12-16
Clinical trial
Phase I Clinical Trial of SyB L-1101 in Patients With Myelodysplastic SyndromeStatus: Completed, Estimated PCD: 2015-02-01
Clinical trial
Phase I Clinical Trial of SyB C-1101 in Patients With Myelodysplastic SyndromeStatus: Completed, Estimated PCD: 2014-11-01
Clinical trial
A Multicenter, Open-label Phase III Study of SyB L-0501 in Combination With Rituximab in Patients With Recurrent or Relapsed Diffuse Large B-Cell LymphomaStatus: Completed, Estimated PCD: 2019-12-31
Clinical trial
Double-Blind, Placebo-Controlled Comparative Study of SyB P-1501 (Fentanyl HCI) for Treatment of Postoperative PainStatus: Terminated, Estimated PCD: 2017-07-21
Clinical trial
A Phase 1, Open Label, Multicentre Clinical Trial of SyB C-1101 in Combination With Azacytidine in Patients With Myelodysplastic SyndromeStatus: Withdrawn, Estimated PCD: 2017-06-01
Clinical trial
A Multicenter, Open-label, Phase I/II Study to Investigate the Safety and Tolerability of SyB L-0501RI (Bendamustine Hydrochloride for Injection) Administered As an Intravenous (IV) Rapid Infusion Over 10 MinutesStatus: Completed, Estimated PCD: 2020-09-09
Clinical trial
Multi-center, Open-label, Phase I Study of SyB C-1101 in Patients With Myelodysplastic SyndromeStatus: Completed, Estimated PCD: 2019-05-28
Clinical trial
A Phase IIa, Open-label, Multiple Ascending Dose Confirmation Study of the Safety and Tolerability of Intravenous Administration of Brincidofovir in Subjects With Adenovirus InfectionStatus: Recruiting, Estimated PCD: 2026-09-30